What is Willful Patent Infringement?

American biopharmaceutical Gilead Sciences was hit with a $2.5 billion verdict in a patent jury trial against another pharmaceutical last year. But the company escaped another intellectual property case unharmed last week, avoiding what could have been a second $2.5 billion verdict. U.S. District Judge Leonard Stark in Delaware recently ruled that biopharmaceutical company’s conduct concerning its blockbuster hepatitis C (HCV) medication sofosvubir didn’t …